Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2018 · 10-Q
Revenue$1.65M$1.65M−16.7% vs Q2 2017 Net Income-$1.88M-$1.88MN/M vs Q2 2017 EPS Diluted-$0.17-$0.17N/M vs Q2 2017 Operating Income-$1,635,938N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,143,110— Margins · derivedOperating margin-99.4%−7.1 pt vs Q2 2017
Net margin-114.0%−12.5 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end